Physician profile
Barry Aron
NPI 1275528663
$6,395.82
in general payments reported to CMS, 2019-2025
27 companies · $52.21 in 2025
The $52.21 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $89.73 · 2021: $147 · 2022: $412 · 2023: $3,527 · 2024: $1,760 · 2025: $52.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,575 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,574.57 |
| Food and Beverage | $763.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,614.99 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $262.41 | 2019-2024 | Enseal, Stratafix, Ethicon |
| Bayer Healthcare Pharmaceuticals INC. | $221.60 | 2019-2024 | |
| Abbvie INC. | $220.11 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $190.68 | 2023-2025 | Veozah |
| Pfizer INC. | $125.35 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $123.93 | 2023-2024 | Myfembree, Gemtesa |
| Organon LLC | $86.09 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $73.33 | 2019-2021 | |
| Hologic Sales and Service, LLC | $49.46 | 2019-2024 | Aptima |
| Allergan, INC. | $44.11 | 2019 | |
| Duchesnay USA Incorporated | $43.82 | 2019 | |
| Therapeuticsmd, INC. | $40.93 | 2019-2021 | |
| Novo Nordisk INC | $30.22 | 2023 | |
| Mayne Pharma Commercial LLC | $29.44 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $26.79 | 2023 | Wallach Cryosurgical Equipment |
| Exeltis, USA INC. | $23.61 | 2023 | Slynd |
| Aspira Women'S Health INC | $23.37 | 2022 | |
| Agile Therapeutics, INC. | $22.14 | 2022 | |
| Myovant Sciences INC. | $22.09 | 2022 | |
| Amgen INC. | $21.66 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.67 | 2019 | |
| Minerva Surgical, INC | $18.36 | 2022 | |
| Evofem Biosciences, INC. | $18.15 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.71 | 2019 | |
| Scynexis, INC. | $14.35 | 2021 | |
| Mckesson Patient Care Solutions INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Aron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.